Results for "HDA Factbook"
Leveraging Public and Private Sector Collaboration to Respond to COVID-19
While it has only been a few months since the first American was diagnosed with COVID-19, the scope of the pandemic is one which we have never experienced before. Throughout, it has become abundantly clear that our nation’s ability to effectively respond to this once-in-a-lifetime crisis depends on the public and private sectors joining forces, maintaining constant coordination, and working together to identify operational and regulatory barriers impeding access to medicines and medical supplies.
HDA’s Chip Davis Assesses State of the Distribution Industry at 2021 BLC Online
HDA President and CEO Chip Davis recently spoke at the 2021 BLC Online about the unique role of the healthcare distribution industry in combating COVID-19, how distributors continue to rise to its challenges and what is still needed to turn the corner on the pandemic, among other association priorities.
Latest Faces of the Supply Chain Videos Underscore Industry’s Focus on Safety and Reliability
HDA’s Faces of the Supply Chain series continued this past month with the release of new videos featuring perspectives from nine distribution sector experts. Interviews touched upon topics ranging from innovations in healthcare distribution and manufacturing; the industry’s focus on patients; supply chain resilience through the COVID-19 pandemic; and more.
Envisioning the Future of the Pharmaceutical Supply Chain
Through a collaboration with the Milken Institute, HDA, along with diverse thought leaders and experts, provided expertise to inform a new report from the Milken Institute’s Center for Public Health. The report “Envisioning the Future of the Pharmaceutical Supply Chain to Advance Public Health in the United States,” emphasizes how a resilient pharmaceutical supply chain bolsters a strong public health infrastructure in the U.S, and brings a greater focus and awareness into supply chain collaboration to create an enhanced public health environment that is equitable, sustainable and resilient.
The Pending NDC and Barcode Rule: Healthcare IT Company Perspectives
With the Food and Drug Administration’s (FDA) final rule covering amendments to its National Drug Code (NDC)1 and barcode rules anticipated in early 2024, it is essential for organizations throughout the supply chain to prepare for this regulation.
We continue our review of comments to the FDA’s proposal by summarizing responses submitted by organizations within the healthcare IT industry.